Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery

Abstract

Stenting of the popliteal artery using the Supera stent system appears to be safe and effective. The interwoven stent design may better serve areas under extreme mechanical stress. Our results with this highly diseased patient population justify a prospective trial in this subject.

Stenting of femoropopliteal lesions using interwoven nitinol stents

“…Importantly, early and midterm results in Germany, Asia, the United States, and our series have shown complete freedom from stent fracture with the Supera stent, even when it is used in the proximal to mid popliteal artery. [12][13][14][15] Recently reported outcomes with drug-eluting stents have also shown increased patency compared with nondrug-eluting stents. Indeed, the patency rates reported with Supera appear equivalent to the results with the Zilver drug-eluting stent in short lesions.…”

Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years

“…Thus, stents with increased radial force and flexibility could serve better the demands of this anatomical territory. 25,26 A recently published study evaluating combined directional atherectomy and DEB treatment for isolated popliteal lesions suggests that "leave nothing behind strategies" could overcome the challenges arising from the mobility of the knee joint. 27 Notably, popliteal involvement did not affect the PPR and SPR in this cohort.…”

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease

“…León et al 18 showed in a cohort of 34 patients with 39 stents placed in the isolated popliteal artery that the primary, primary assisted, and secondary patency rates by duplex ultrasound imaging were 79.2%, 88.1%, and 93%, respectively. Six stent occlusions occurred, and six patients had hemodynamically significant in-stent restenosis.…”